Minjie Zhao

3Department Of Ophthalmology, No.75 Tongzhenguan Road
Yicheng, 214200, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Non-Stoichiometric Strategy Induced Luminescence Improvement of the Cyan-Emitting Phosphor Ca3Sc2Si3O12:Ce3+ for WLED.

Non-Stoichiometric Strategy Induced Luminescence Improvement of the Cyan-Emitting Phosphor Ca3Sc2Si3O12:Ce3+ for WLED.

Journal: Luminescence : the journal of biological and chemical luminescence

Published: July 09, 2025

Calcium Vacancy Generated Luminescence Improvement of the Ca3Sc2Si3O12:Ce3+ Phosphor for WLED.

Calcium Vacancy Generated Luminescence Improvement of the Ca3Sc2Si3O12:Ce3+ Phosphor for WLED.

Journal: Luminescence : the journal of biological and chemical luminescence

Published: June 17, 2025

Aqueous Humor Biomarkers of Retinal Glial Cell Activation in Patients With or Without Age-Related Cataracts and With Different Stages of Diabetic Retinopathy.

Aqueous Humor Biomarkers of Retinal Glial Cell Activation in Patients With or Without Age-Related Cataracts and With Different Stages of Diabetic Retinopathy.

Journal: Investigative ophthalmology & visual science

Published: March 09, 2022

The Role of the AIMP1 Pathway in Diabetic Retinopathy: AIMP1-Targeted Intervention Study in Diabetic Retinopathy.

The Role of the AIMP1 Pathway in Diabetic Retinopathy: AIMP1-Targeted Intervention Study in Diabetic Retinopathy.

Journal: Ophthalmic research

Published: July 17, 2019

ASK1 induces retinal microvascular endothelial cell apoptosis through ER stress-associated pathway.

ASK1 induces retinal microvascular endothelial cell apoptosis through ER stress-associated pathway.

Journal: International journal of clinical and experimental pathology

Published: December 26, 2018

Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection.

Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection.

Journal: Journal of ophthalmology

Published: January 09, 2018

Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis.

Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis.

Journal: Clinical proteomics

Published: November 25, 2017

Corrigendum: Diabetes Onset at 31-45 Years of Age is Associated with an Increased Risk of Diabetic Retinopathy in Type 2 Diabetes.

Corrigendum: Diabetes Onset at 31-45 Years of Age is Associated with an Increased Risk of Diabetic Retinopathy in Type 2 Diabetes.

Journal: Scientific reports

Published: May 27, 2017

Diabetes Onset at 31-45 Years of Age is Associated with an Increased Risk of Diabetic Retinopathy in Type 2 Diabetes.

Diabetes Onset at 31-45 Years of Age is Associated with an Increased Risk of Diabetic Retinopathy in Type 2 Diabetes.

Journal: Scientific reports

Published: June 23, 2016

Preoperative intravitreal injection of ranibizumab for patients with severe proliferative diabetic retinopathy contributes to a decreased risk of postoperative neovascular glaucoma.

Preoperative intravitreal injection of ranibizumab for patients with severe proliferative diabetic retinopathy contributes to a decreased risk of postoperative neovascular glaucoma.

Journal: Acta ophthalmologica

Published: March 25, 2016

Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.

Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: January 09, 2016

ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy.

ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: June 05, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026